Sort
17,828 grants matching “crispr”
Identification of Pathways Required for High Glucose-Induced Oxidative Stress Associated With Diabetic Embryopathy by CRISPR-Generated Mutation Screen
$253,500Mary R Loeken · Joslin Diabetes Center · R21 · FY2020 · HD
Long-term risk for psychiatric disorders following early life exposure to environmental arsenic
$253,500James A Coffman · Mount Desert Island Biological Lab · R21 · FY2024 · ES
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
$253,224Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Rapid Genotyping of ApoL1 Risk Alleles using CRISPR-Cas12a
$253,103Christopher P Larsen · Nephropathology Associates · R43 · FY2021 · DK
C/EBPβ in bone marrow stromal cell-mediated drug resistance of multiple myeloma
$253,063Gangqing Hu · West Virginia University · P20 · FY2025 · GM
Computationally Enabled Integrative Neuroscience
$252,970James J Dicarlo · Massachusetts Institute Of Technology · T32 · FY2020 · NS
Bacterial CRISPR interference to define macrophage responses to group B Streptococcus proteins
$252,913Thomas A Hooven · University Of Pittsburgh At Pittsburgh · R21 · FY2023 · AI
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
$252,750Jun Yang · University Of Texas Med Br Galveston · R21 · FY2021 · AI
Understanding and addressing sub-optimal responses to CAR T cell therapy for Multiple Myeloma
$252,737Eric L Smith · Dana-Farber Cancer Inst · K08 · FY2023 · CA
Understanding and addressing sub-optimal responses to CAR T cell therapy for Multiple Myeloma
$252,737Eric L Smith · Dana-Farber Cancer Inst · K08 · FY2021 · CA
Understanding and addressing sub-optimal responses to CAR T cell therapy for Multiple Myeloma
$252,737Eric L Smith · Dana-Farber Cancer Inst · K08 · FY2022 · CA
Understanding and addressing sub-optimal responses to CAR T cell therapy for Multiple Myeloma
$252,737Eric L Smith · Dana-Farber Cancer Inst · K08 · FY2020 · CA
Core 1: Functional Genomics and Proteomics
$252,318Nevan J Krogan · University Of California, San Francisco · U54 · FY2024 · CA
Project 2: Next Generation TOP1 Inhibition for the Treatment of Ovarian Cancer
$252,226Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2025 · CA
Discovery and applications of CRISPR-Cas inhibitor proteins
$252,131David Rabuka · Acrigen Biosciences, Inc. · R43 · FY2020 · GM
Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome
$252,000Herbert M Lachman · Albert Einstein College Of Medicine · R21 · FY2024 · MH
Host Responses to Coccidioides by Human Airway Epithelium
$252,000Jatin M Vyas · Massachusetts General Hospital · R21 · FY2022 · AI
Transcriptional Regulation of the Il13 Gene in Mast Cells
$251,972Hua Huang · National Jewish Health · R56 · FY2024 · AI
Feasibility of INSPIRE Technology to Enhance CRISPR Mediated Genome Editors In Vivo
$251,914Jordan Fong · Gradient Medical, Inc. · R43 · FY2021 · GM
Biological Core
$251,382Carolyn Ann Worby · University Of Kentucky · P01 · FY2017 · NS
Functionally dissecting the transcriptional regulatory network of the innate immune response using CRISPR-effectors
$251,250Rene Maehr · Univ Of Massachusetts Med Sch Worcester · R21 · FY2015 · AI
Defining epistatic interactions among Coxiella burnetii effector proteins using a CRISPRi approach
$251,250Craig R. Roy · Yale University · R21 · FY2022 · AI
Identification of Novel Regulators for Neutrophil Development and Lifespan
$251,250Wenwen Tang · Yale University · R21 · FY2024 · AI
A comprehensive gene repair therapy for FKRP neuromuscular diseases
$251,250Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · R21 · FY2018 · NS
Host genes controlling rodent protoparvovirus tissue and species tropism
$251,250Peter Tattersall · Yale University · R21 · FY2021 · AI